Millipore Sigma Vibrant Logo

375670 Herbimycin A, Streptomyces sp. - CAS 70563-58-5 - Calbiochem

A potent and cell-permeable protein tyrosine kinase inhibitor.

Ficha de datos de seguridad (MSDS o SDS), certificado de análisis y de calidad (CoA y CoQ), expedientes, folletos y otros documentos disponibles.
Primary Target: P60v-src
View Products on Sigmaaldrich.com
375670
  
Recuperando precio...
No pudo obtenerse el precio
La cantidad mínima tiene que ser múltiplo de
Maximum Quantity is
Al finalizar el pedido Más información
Ahorró ()
 
—
Solicitar precio
—
Disponibilidad a confirmar Disponibilidad a confirmar
Ingrese cantidad 
Suspendido
Cantidades limitadas disponibles
Debe confirmarse disponibilidad
    El resto: se avisará
      El resto: se avisará
      Se avisará
      Póngase en contacto con el Servicio de Atención al Cliente
      Contact Customer Service

       

      Póngase en contacto con el Servicio de Atención al Cliente

      Descripción

      Replacement Information

      Tabla espec. clave

      CAS #Empirical Formula
      70563-58-5C₃₀H₄₂N₂O₉
      Description
      OverviewA potent and cell-permeable protein tyrosine kinase inhibitor. Inhibits p60v-src (IC50 = 12 µM) and PDGF-induced phospholipase D activation (IC50 = 8 µg/ml). Reported to inhibit c-Src related bone resorption (IC50 = 70 nM). Inhibits angiogenesis in chick chorioallantoic membrane. Also shown to inhibit anti-CD3 monoclonal antibody-induced apoptosis of thymocytes.
      Catalogue Number375670
      Brand Family Calbiochem®
      References
      ReferencesFan, T.-P., et al. 1995. Trends Pharmacol. Sci. 16, 57.
      Kim, B.Y. 1995. Biochem. Biophys. Res. Commun. 212, 1061.
      Migita, K., et al. 1994. J. Immunol. 153, 3457.
      Okabe, M., et al. 1994. Leuk. Res. 18, 867.
      Fukazawa, H., et al. 1991. Biochem. Pharmacol. 42, 1661.
      Obinata, A., et al. 1991. Exp. Cell Res. 193, 36.
      Park, D.J., et al. 1991. J. Biol. Chem. 266, 24237.
      Weinstein, S.L., et al. 1991. Proc. Natl. Acad. Sci. USA 88, 4148.
      Oikawa, T., et al. 1989. Cancer Lett. 48, 157.
      Uehara, Y., et al. 1989. Biochem. Biophys. Res. Commun. 163, 803.
      Uehara, Y., et al. 1988. Virology 164, 294.
      Omura, S., et al. 1979. J. Antibiotics 32, 255.
      Product Information
      CAS number70563-58-5
      ATP CompetitiveN
      FormYellow solid
      Hill FormulaC₃₀H₄₂N₂O₉
      Chemical formulaC₃₀H₄₂N₂O₉
      ReversibleN
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Primary TargetP60v-src
      Primary Target IC<sub>50</sub>12 µM against P60v-src
      Purity≥95% by HPLC
      Physicochemical Information
      Cell permeableY
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      RTECSLX8930000
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Carcinogenic / Teratogenic
      Storage -20°C
      Protect from Light Protect from light
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). DMSO stock solutions are stable for up to 6 months at -20°C.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Número de referencia GTIN
      375670 0

      Documentation

      Herbimycin A, Streptomyces sp. - CAS 70563-58-5 - Calbiochem Ficha datos de seguridad (MSDS)

      Título

      Ficha técnica de seguridad del material (MSDS) 

      Herbimycin A, Streptomyces sp. - CAS 70563-58-5 - Calbiochem Certificados de análisis

      CargoNúmero de lote
      375670

      Referencias bibliográficas

      Visión general referencias
      Fan, T.-P., et al. 1995. Trends Pharmacol. Sci. 16, 57.
      Kim, B.Y. 1995. Biochem. Biophys. Res. Commun. 212, 1061.
      Migita, K., et al. 1994. J. Immunol. 153, 3457.
      Okabe, M., et al. 1994. Leuk. Res. 18, 867.
      Fukazawa, H., et al. 1991. Biochem. Pharmacol. 42, 1661.
      Obinata, A., et al. 1991. Exp. Cell Res. 193, 36.
      Park, D.J., et al. 1991. J. Biol. Chem. 266, 24237.
      Weinstein, S.L., et al. 1991. Proc. Natl. Acad. Sci. USA 88, 4148.
      Oikawa, T., et al. 1989. Cancer Lett. 48, 157.
      Uehara, Y., et al. 1989. Biochem. Biophys. Res. Commun. 163, 803.
      Uehara, Y., et al. 1988. Virology 164, 294.
      Omura, S., et al. 1979. J. Antibiotics 32, 255.

      Folleto

      Cargo
      Caspases and other Apoptosis Related Tools Brochure

      Citas

      Título
    • Satoshi Fukumoto, et al. (2006) Laminin 5 is required for dental epithelium growth and polarity and the development of tooth bud and shape. Journal of Biological Chemistry 281, 5008-5016.
    • Dylan T. Jones, et al. (2004) Geldanamycin and herbimycin A induce apoptotic killing of B chronic lymphocytic leukemia cells and augment the cells' sensitivity to cytotoxic drugs. Blood 103, 1855-1861.
      		•
      Ficha técnica

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision09-July-2008 RFH
      DescriptionA cell-permeable, potent inhibitor of protein tyrosine kinases. Inhibits p60v-src (IC50 = 12 µM) autophosphorylation. Irreversibly binds to the sulfhydryl groups of the kinase. Dose-dependently inhibits PDGF-induced phospholipase D activation (IC50 = 8 µg/ml). Also, reported to inhibit c-src related bone resorption (IC50 = 70 nM). Inhibits angiogenesis in chick chorioallantoic membrane and blocks anti-CD3 monoclonal antibody-induced apoptosis of thymocytes. Several mammalian cell lines transformed with tyrosine kinase oncogenes (src, abl, fps, ros, yes, erbB) show reversion from the transformed to the normal phenotype after treatment with herbimycin A.
      FormYellow solid
      CAS number70563-58-5
      RTECSLX8930000
      Chemical formulaC₃₀H₄₂N₂O₉
      Structure formulaStructure formula
      Purity≥95% by HPLC
      SolubilityDMSO (1 mg/ml). Further dilute with H₂O or aqueous buffers just prior to use.
      Storage Protect from light
      -20°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). DMSO stock solutions are stable for up to 6 months at -20°C.
      Toxicity Carcinogenic / Teratogenic
      ReferencesFan, T.-P., et al. 1995. Trends Pharmacol. Sci. 16, 57.
      Kim, B.Y. 1995. Biochem. Biophys. Res. Commun. 212, 1061.
      Migita, K., et al. 1994. J. Immunol. 153, 3457.
      Okabe, M., et al. 1994. Leuk. Res. 18, 867.
      Fukazawa, H., et al. 1991. Biochem. Pharmacol. 42, 1661.
      Obinata, A., et al. 1991. Exp. Cell Res. 193, 36.
      Park, D.J., et al. 1991. J. Biol. Chem. 266, 24237.
      Weinstein, S.L., et al. 1991. Proc. Natl. Acad. Sci. USA 88, 4148.
      Oikawa, T., et al. 1989. Cancer Lett. 48, 157.
      Uehara, Y., et al. 1989. Biochem. Biophys. Res. Commun. 163, 803.
      Uehara, Y., et al. 1988. Virology 164, 294.
      Omura, S., et al. 1979. J. Antibiotics 32, 255.
      Citation
    • Satoshi Fukumoto, et al. (2006) Laminin 5 is required for dental epithelium growth and polarity and the development of tooth bud and shape. Journal of Biological Chemistry 281, 5008-5016.
    • Dylan T. Jones, et al. (2004) Geldanamycin and herbimycin A induce apoptotic killing of B chronic lymphocytic leukemia cells and augment the cells' sensitivity to cytotoxic drugs. Blood 103, 1855-1861.
      		•